Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Friday's Intraday Session

Author: Benzinga Insights | February 03, 2023 01:31pm

Gainers

  • Reshape Lifesciences (NASDAQ:RSLS) stock moved upwards by 163.5% to $16.6 during Friday's regular session. As of 12:30 EST, Reshape Lifesciences's stock is trading at a volume of 8.2 million, which is 3041.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $8.6 million.
  • Genetic Technologies (NASDAQ:GENE) stock increased by 73.76% to $1.75. Trading volume for this security as of 12:30 EST is 78.1 million, which is 39719.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $27.0 million.
  • Heart Test Laboratories (NASDAQ:HSCS) shares rose 62.05% to $2.3. As of 12:30 EST, this security is trading at a volume of 30.2 million shares, making up 2201.1% of its average full-day volume over the last 100 days. The company's market cap stands at $19.2 million.
  • AlerisLife (NASDAQ:ALR) shares increased by 58.06% to $1.28. As of 12:30 EST, this security is trading at a volume of 3.2 million shares, making up 3152.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $41.7 million.
  • Magenta Therapeutics (NASDAQ:MGTA) shares increased by 40.54% to $0.79. Magenta Therapeutics's stock is trading at a volume of 23.2 million shares as of 12:30 EST. This is 1222.3% of its average full-day volume over the last 100 days. The company's market cap stands at $48.0 million.
  • Bright Green (NASDAQ:BGXX) stock rose 37.26% to $1.46. As of 12:30 EST, this security is trading at a volume of 29.2 million shares, making up 1015.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $246.3 million.

Losers

  • MDxHealth (NASDAQ:MDXH) stock fell 36.8% to $3.8 during Friday's regular session. Trading volume for MDxHealth's stock is 1.4 million as of 12:30 EST. This is 58963.2% of its average full-day volume over the last 100 days. The company's market cap stands at $61.8 million.
  • Cellectis (NASDAQ:CLLS) stock fell 24.24% to $2.47. Trading volume for this security as of 12:30 EST is 1.2 million, which is 1092.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $112.5 million.
  • Summit Therapeutics (NASDAQ:SMMT) stock fell 22.94% to $2.99. Trading volume for this security as of 12:30 EST is 5.3 million, which is 55.7% of its average full-day volume over the last 100 days. The company's market cap stands at $631.8 million.
  • Tenax Therapeutics (NASDAQ:TENX) stock decreased by 20.37% to $1.76. Trading volume for this security as of 12:30 EST is 6.4 million, which is 761.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $4.0 million.
  • Vyant Bio (NASDAQ:VYNT) shares decreased by 18.9% to $0.84. As of 12:30 EST, Vyant Bio's stock is trading at a volume of 448.5K, which is 111.7% of its average full-day volume over the last 100 days. The company's market cap stands at $4.9 million.
  • Twist Bioscience (NASDAQ:TWST) shares declined by 16.54% to $25.79. Trading volume for Twist Bioscience's stock is 1.5 million as of 12:30 EST. This is 119.7% of its average full-day volume over the last 100 days. The company's market cap stands at $1.4 billion. As per the news, the Q1 earnings report came out today. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ALR BGXX CLLS GENE HSCS MDXH MGTA RSLS SMMT TENX TWST VYNT

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist